Fulgent Genetics (NASDAQ: FLGT)
Fulgent Genetics Return vs. S&P
1 Year | 5 Year | 5 Year Annualized | Since IPO |
---|
Fulgent Genetics Company Info
Fulgent Genetics is a technology company that provides comprehensive diagnostic genetic testing using its proprietary platform, which integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools, and integrated laboratory processes.
News & Analysis
Got $2,500? This Dirt Cheap Growth Stock Could Be Worth Buying Hand Over Fist
Fulgent is moving past its pandemic-era business, and that's a good thing.
1 Green Flag and 1 Red Flag for Fulgent Genetics After Earnings
Strong core business growth was overshadowed in Q3 by an acquisition.
Why I Bought More of This Under-the-Radar Stock
This healthcare business has tailwinds behind it.
2 No-Brainer Stocks to Buy Right Now for Less than $55
These companies have low share prices and high potential.
This Stock Grew 135% Last Year and Is Down 50% From Its Highs
Is Fulgent an underrated stock or a value trap?
This News Just Put Fulgent at the Top of My Buy List
An acquisition and raised guidance have reinforced the bull case for the stock.
Got $5,000? Grow It With These 2 Innovative Healthcare Stocks
They're churning out new products while making headway into their massive markets.
Got $5,000? 3 Growth Stocks to Buy That Could Double Your Money
They have a whole lot going right, and little in the way of obstacles.
Valuation
Earnings Transcripts
Fulgent Genetics, Inc. (FLGT) Q2 2022 Earnings Call Transcript
FLGT earnings call for the period ending June 30, 2022.
Fulgent Genetics, Inc. (FLGT) Q1 2022 Earnings Call Transcript
FLGT earnings call for the period ending March 31, 2022.
Fulgent Genetics, Inc. (FLGT) Q4 2021 Earnings Call Transcript
FLGT earnings call for the period ending December 31, 2021.
Fulgent Genetics, Inc. Common Stock (FLGT) Q3 2021 Earnings Call Transcript
FLGT earnings call for the period ending September 30, 2021.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.